Crossmark

Bioarchaeological evidence of mycoses during the Late Antiquity–Early Middle Ages transition in Central Italy

Crossref DOI link: https://doi.org/10.1038/s41598-026-65544-y

Published Online: 2026-09-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Buzi, Costantino https://orcid.org/0000-0001-8951-2990
Merola, Antonio

Messineo, Daniela https://orcid.org/0000-0003-3059-4439
Ostrosky-Zeichner, Luis https://orcid.org/0000-0002-4784-7589
Paine, Robert R.

Manzi, Giorgio https://orcid.org/0000-0002-8611-1371
Smith, Dallas J. https://orcid.org/0000-0001-5707-528X
Micarelli, Ileana https://orcid.org/0000-0001-7498-5218
Funding

Funding for this research was provided by:

University and Research and European Union – NextGenerationEU (CUP: J93C25000650001)

National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (UL1TR003167)

Centers for Disease Control and Prevention (contract U01CK000692)

Fondazione CHANGES (grant PE0000020)

Fondazione CHANGES (grant PE0000020)

Marie Sklodowska-Curie Postdoctoral Fellowships 2021 (grant 101061838)

Fondo Italiano per la Scienza (FIS 2024-00697)
License Information

Text and Data Mining valid from 2026-09-01

Version of Record valid from 2026-09-01
More Information

Article History

Received: 23 September 2025

Accepted: 31 July 2026

First Online: 1 September 2026

Declarations

Competing interests: Pertinent to this work, LO has received research grants and/or consulting honoraria from the following companies: Scynexis, Melinta, GSK, Pulmocide, F2G, Basilea, Pfizer, Gilead, T2 biosystems, Octapharma, Meiji, Stendhal, Knight, IMMY, Karius, Doximity, Incyte, CSL, and Eurofins Viracor. The rest of the authors declare that they have no competing interests.

Document is current

Any future updates will be listed below